CVS vs PYXS · P/E 16, rev $402.07B vs rev $2.8M
CVS Health Corp (CVS) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported CVS revenue for 2025-12-31 was $402.07B. Net income was $1.77B. Revenue was up 7.8% from 2024-12-31 to 2025-12-31. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the CVS and PYXS stock pages for the full models.
Not investment advice.